Contact Us

HOTEL NEWS

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Feb 7, 2025

Late-stage Alzheimer\'s trial opens 10 new sites in USA,with results due in 2025 and 2026 SYDNEY,Feb. 5,2025-- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO)

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th

Feb 7, 2025

NEW YORK,Feb. 5,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insights

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Feb 7, 2025

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

Strong stakeholder engagement towards Minesto's first tidal energy Dragon farm in Hestfjord, Faroe Islands

Feb 7, 2025

GOTHENBURG,Sweden,Feb. 6,2025-- On Monday 3rd February,ocean energy developer Minesto welcomed Faroese stakeholders,authorities as well as the public to a seminar at the Nordic House in Torshavn. Mart

NaaS Technology Inc. Achieves Strong Demand-side Growth in Charging Service Business, Covering Over 60% of China's NEV Owners

Feb 7, 2025

BEIJING,Feb. 6,2025-- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"),the first U.S.-listed EV charging service company in China,today announced substantial expansion

PT Lippo General Insurance Tbk (LGI) Unveils MyGo+: A Telematics-Based App for Safer Driving

Feb 7, 2025

JAKARTA,Indonesia,Feb. 6,2025--PT Lippo General Insurance Tbk (LGI),a leading general insurance company in Indonesia,has announced the launch of MyGo+,a telematics-based app designed to encourage safe

1 ... 97 98 99 100 101 102 103 ... 344